table of content
1 Study Coverage
1.1 Dermatological Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prescription-Based Drugs
1.2.3 Over-the-Counter Drugs
1.3 Market by Application
1.3.1 Global Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatological Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Dermatological Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Dermatological Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dermatological Drugs Sales by Region
2.4.1 Global Dermatological Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Dermatological Drugs by Region (2023-2028)
2.5 Global Dermatological Drugs Revenue by Region
2.5.1 Global Dermatological Drugs Revenue by Region (2017-2022)
2.5.2 Global Dermatological Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermatological Drugs Sales by Manufacturers
3.1.1 Global Top Dermatological Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Dermatological Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermatological Drugs in 2021
3.2 Global Dermatological Drugs Revenue by Manufacturers
3.2.1 Global Dermatological Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Dermatological Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dermatological Drugs Revenue in 2021
3.3 Global Dermatological Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermatological Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermatological Drugs Sales by Type
4.1.1 Global Dermatological Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Dermatological Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Dermatological Drugs Sales Market Share by Type (2017-2028)
4.2 Global Dermatological Drugs Revenue by Type
4.2.1 Global Dermatological Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Dermatological Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dermatological Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Dermatological Drugs Price by Type
4.3.1 Global Dermatological Drugs Price by Type (2017-2022)
4.3.2 Global Dermatological Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dermatological Drugs Sales by Application
5.1.1 Global Dermatological Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Dermatological Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Dermatological Drugs Sales Market Share by Application (2017-2028)
5.2 Global Dermatological Drugs Revenue by Application
5.2.1 Global Dermatological Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Dermatological Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dermatological Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Dermatological Drugs Price by Application
5.3.1 Global Dermatological Drugs Price by Application (2017-2022)
5.3.2 Global Dermatological Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dermatological Drugs Market Size by Type
6.1.1 North America Dermatological Drugs Sales by Type (2017-2028)
6.1.2 North America Dermatological Drugs Revenue by Type (2017-2028)
6.2 North America Dermatological Drugs Market Size by Application
6.2.1 North America Dermatological Drugs Sales by Application (2017-2028)
6.2.2 North America Dermatological Drugs Revenue by Application (2017-2028)
6.3 North America Dermatological Drugs Market Size by Country
6.3.1 North America Dermatological Drugs Sales by Country (2017-2028)
6.3.2 North America Dermatological Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermatological Drugs Market Size by Type
7.1.1 Europe Dermatological Drugs Sales by Type (2017-2028)
7.1.2 Europe Dermatological Drugs Revenue by Type (2017-2028)
7.2 Europe Dermatological Drugs Market Size by Application
7.2.1 Europe Dermatological Drugs Sales by Application (2017-2028)
7.2.2 Europe Dermatological Drugs Revenue by Application (2017-2028)
7.3 Europe Dermatological Drugs Market Size by Country
7.3.1 Europe Dermatological Drugs Sales by Country (2017-2028)
7.3.2 Europe Dermatological Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermatological Drugs Market Size by Type
8.1.1 Asia Pacific Dermatological Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Dermatological Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Dermatological Drugs Market Size by Application
8.2.1 Asia Pacific Dermatological Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Dermatological Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Dermatological Drugs Market Size by Region
8.3.1 Asia Pacific Dermatological Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Dermatological Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermatological Drugs Market Size by Type
9.1.1 Latin America Dermatological Drugs Sales by Type (2017-2028)
9.1.2 Latin America Dermatological Drugs Revenue by Type (2017-2028)
9.2 Latin America Dermatological Drugs Market Size by Application
9.2.1 Latin America Dermatological Drugs Sales by Application (2017-2028)
9.2.2 Latin America Dermatological Drugs Revenue by Application (2017-2028)
9.3 Latin America Dermatological Drugs Market Size by Country
9.3.1 Latin America Dermatological Drugs Sales by Country (2017-2028)
9.3.2 Latin America Dermatological Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dermatological Drugs Market Size by Type
10.1.1 Middle East and Africa Dermatological Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dermatological Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Dermatological Drugs Market Size by Application
10.2.1 Middle East and Africa Dermatological Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dermatological Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Dermatological Drugs Market Size by Country
10.3.1 Middle East and Africa Dermatological Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dermatological Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Overview
11.6.3 F. Hoffmann-La Roche Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 F. Hoffmann-La Roche Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 F. Hoffmann-La Roche Recent Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Overview
11.7.3 Allergan Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allergan Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan Recent Developments
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Corporation Information
11.8.2 Valeant Pharmaceuticals Overview
11.8.3 Valeant Pharmaceuticals Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Valeant Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Valeant Pharmaceuticals Recent Developments
11.9 PharmaDerm Pharmaceuticals
11.9.1 PharmaDerm Pharmaceuticals Corporation Information
11.9.2 PharmaDerm Pharmaceuticals Overview
11.9.3 PharmaDerm Pharmaceuticals Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PharmaDerm Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PharmaDerm Pharmaceuticals Recent Developments
11.10 Allergan Inamed Corporation
11.10.1 Allergan Inamed Corporation Corporation Information
11.10.2 Allergan Inamed Corporation Overview
11.10.3 Allergan Inamed Corporation Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Allergan Inamed Corporation Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Allergan Inamed Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dermatological Drugs Industry Chain Analysis
12.2 Dermatological Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermatological Drugs Production Mode & Process
12.4 Dermatological Drugs Sales and Marketing
12.4.1 Dermatological Drugs Sales Channels
12.4.2 Dermatological Drugs Distributors
12.5 Dermatological Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermatological Drugs Industry Trends
13.2 Dermatological Drugs Market Drivers
13.3 Dermatological Drugs Market Challenges
13.4 Dermatological Drugs Market Restraints
14 Key Findings in The Global Dermatological Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
